Drug Discov Ther. 2021;15(1):42-43. (DOI: 10.5582/ddt.2020.03111)
COVID-19 in patients living with human immunodeficiency virus (HIV) infection: Challenges and way-forward
Bhatt M, Soneja M, Gupta N
Most studies have described worse outcomes with coronavirus disease 2019 (COVID‐19) in patients with human immunodeficiency virus (HIV). This has been attributed to COVID-19 associated lymphopenia (resulting in lower CD4 count), higher prevalence of comorbidities (established risk factors for severity in COVID-19) and pre-existing lung damage. The problem has been further aggravated by the lack in the access to routine care in HIV patients due to diversion of resources. In this article, we discuss the impact of COVID‐19 on patients with HIV infection.